RADIOSELECTAN URINAIRE 30 % (146 mg d'Iode/ml), solution for injection bottle, 250 ml
Active ingredients: Diatrizoate meglumine, Diatrizoate sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 250 mlintraartérielle;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RADIOSELECTAN URINAIRE 30 POUR CENT (146 mg d'Iode/ml), solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraartérielle;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 250 ml
- Marketing authorisation holder
- BAYER HEALTHCARE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Jul 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67940065CIP73089466CIP133400930894668Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AMIDOTRIZOATE DE SODIUMsolution | 3,956 g · 100 ml de solution injectable | SA |
| AMIDOTRIZOATE DE MÉGLUMINEsolution | 26,044 g · 100 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.